NCT04741412View on ClinicalTrials.gov

Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences

CompletedOBSERVATIONAL
Enrollment

231

Participants

Timeline

Start Date

June 3, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Hypohidrotic Ectodermal Dysplasia
Trial Locations (1)

Unknown

University Hospital Erlangen, Erlangen

All Listed Sponsors
lead

University Hospital Erlangen

OTHER

NCT04741412 - Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences | Biotech Hunter | Biotech Hunter